The California Institute for Regenerative Medicine (CIRM) is a grant funding agency created by the people of California to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world.
To meet this mission, CIRM's team of highly-trained and experienced professionals actively partners with both academia and industry in a hands-on, entrepreneurial environment to fast track the development of today’s most promising stem cell and genetic therapies.
With $5.5 billion in funding and more than 150 active stem cell and genetic therapy programs in our portfolio, CIRM is the world’s largest institution dedicated to helping people by bringing the future of regenerative medicine closer to reality.
L7 Informatics reimagines data intelligence for modern life sciences and healthcare organizations. Beyond simple data management, L7 provides tools that optimize the flow of information between process and people, unlocking innovation at every stage of the clinical, research, and manufacturing value chains. Our comprehensive operating environment and software stack bring flexible, secure, and collaborative data intelligence to your entire operation. From regulatory compliance and workflow orchestration to customized applications and integrations, our end-to-end transformation engine helps organizations solve the challenges of today and realize the opportunities of tomorrow.Visit Website
MaxCyte® is a leading provider of cell-engineering platform technologies and is responsible for helping to bring next‐generation cell-based therapies to life. The Company's technology is employed by leading drug developers worldwide, including 20 of the top 25 global biopharmaceutical companies. Our Flow Electroporation® technology and next-generation ExPERT™ platform enable our partners to accelerate, streamline, and improve the drug development process from the early stages of research to commercialization. Founded in 1998, MaxCyte is headquartered in Gaithersburg, Maryland, U.S.Visit Website
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our technologies enable solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Today, Miltenyi Biotec has more than 3,500 employees in 28 countries – all dedicated to helping researchers and clinicians make a greater impact on science and health.Visit Website
Sony Biotechnology Inc. is dedicated to helping the scientific community of researchers, laboratory professionals, and institutions achieve the best scientific results possible. By leveraging Sony’s comprehensive expertise in electronics innovation and design and with our technological assets we are accelerating development of next-generation cell analysis systems. We bring a unique perspective to science’s high-level instrumentation and are creating innovative products to address our customer’s challenges.Visit Website
As the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support need to accelerate the pace of cell and gene therapy development. We understand the complexity of this rapidly-evolving industry and have made significant investments in cGMP raw material manufacturing and drug product manufacturing capabilities to provide innovative workflow solutions. Partner with us to access the high-quality materials, services, and support you need from discovery to clinical research and commercial cell and gene manufacturing. Through our Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab services, Patheon, and Gibco brands, we offer an unmatched combination of innovative technologies, manufacturing, and distribution capabilities.Visit Website
Mirus Bio is a leading provider of transfection products for the biopharmaceutical and research industries, offering best-in-class reagents for gene therapy, recombinant protein, and stem cell applications. An original pioneer in nucleic acid delivery, the company has been enabling scientific research and innovation for more than two decades. In 2021, Mirus introduced TransIT-VirusGEN® GMP Transfection Reagent and Enhancers to address the commercial biopharmaceutical and cell and gene therapy markets with support for virus manufacturing, gene editing and biotherapeutic protein production.
BioBridge Global is a nonprofit organization committed to saving and enhancing lives through the healing power of human cells and tissue. Through its subsidiaries, South Texas Blood & Tissue, GenCure and QualTex Laboratories, BioBridge Global enables advances in the field of regenerative medicine and advanced therapies through the development and delivery of services from source material collection, donor and product testing, development and manufacturing services as well as logistics management.
Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies that are more affordable and widely available to patients in need. With Cellares’s proprietary platform—the Cell Shuttle—biopharma companies, academic research centers, and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale. The company is headquartered in South San Francisco, CA. For more information visit www.cellares.com.
Corning offers a range of innovative solutions for efficiently scaling up cell cultures for cell and gene therapy research and production. Whether your goal is stem cell expansion or viral vector production, our platforms, including HYPERStack® vessels that maximize cell growth area in a small footprint, the new high-yield Ascent® FBR™ platform, polystyrene and dissolvable microcarriers, and closed system solutions can help get you there. Choose from hundreds of vessels, the widest selection of cell culture surfaces, and custom media in a variety of single-use technology configurations.
FUJIFILM Irvine Scientific supports cell and gene therapy manufacturers with over 50 years of cell culture media knowledge and expertise. Our products advance the development of processes and workflows, to help users obtain optimal performance and safety of their final manufactured cells. We deliver high-performance media and expert support that can directly influence advanced cell and gene therapies. By providing innovative, first-to-market products and workflow solutions, we holistically drive and accelerate user efforts with complete media solutions for basic, translational, and clinical research, as well as commercial applications.
G-CON is fulfilling the needs of reliable and fast deliverable capacities for the biopharmaceutical industry. G-CON provides comprehensive prefabricated and prequalified CGMP compliant cleanroom environments and platforms for uses ranging from laboratory, clinical and commercial production for a variety of therapeutic applications.
Mayo Clinic established the Center for Regenerative Biotherapeutics in 2011 to develop new clinical applications that address the unmet medical needs of patients. The Center for Regenerative Biotherapeutics is enterprise-wide including Florida, Arizona, and Minnesota.
Mayo Clinic and center leaders believe that regenerative biotherapeutics, which makes it possible to actually repair diseased, injured or congenitally defective tissues and organs, will be a vital component of medical and surgical practice in the coming years. By harnessing the potential of regenerative biotherapeutics, Mayo Clinic is poised to create new models of health care and transform medicine and surgery.
A unique aspect of the Center for Regenerative Biotherapeutics is that its activities are not just laboratory based or clinic based. They're both — and everything in between. Efforts in each of the center's programs, which build on Mayo's extensive research resources and clinical practice, span the full spectrum of discovery science, translational research, and clinical application.
In addition to developing regenerative biotherapeutics for patients, the center is also committed to:
Ultimately, this comprehensive approach means that the Center for Regenerative Biotherapeutics has the ability to turn promising laboratory discoveries into proven treatments — and make them available to patients — more effectively and efficiently than most anywhere else.
MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. From solving your unique upstream and downstream challenges, to meeting urgent manufacturing timelines, and navigating uncertain regulatory guidelines, our 30+ years of global expertise integrating leading manufacturing technologies with process development, scale-up, and safety testing is here to help you accelerate your path to cures. Draw on our experience to bring your cell and gene therapies to life.
Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production.
PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases. We work with the world’s leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine. PNI offers proprietary technology platforms and comprehensive expertise to enable researchers to translate disease biology insights into non-viral genetic medicines.
Roche CustomBiotech offers high-quality solutions spanning from cell isolation to quality control release customizable to meet your unique needs. Our offerings include raw materials, PCR-based quality control kits, cell culture analysis instrumentation, and documentation delivering real value in various cell and gene therapy manufacturing workflow steps.Visit Website
High Quality Raw Materials for Cell & Gene Therapy Sartorius CellGenix is a leading global supplier of high quality raw materials for the expanding cell and gene therapy and regenerative medicine space. We develop, manufacture and market human cytokines and growth factors along with GMP serum-free media. To allow for a seamless transition from preclinical development to the clinical stage we offer our human cytokines and growth factors in preclinical and GMP quality. Our products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world. With 25 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space. As a former ATMP developer and manufacturer we gained in-depth cell culture knowledge and superior regulatory expertise. With this unique background we understand the high requirements our customers face during product development and the regulatory approval process. By offering expert technical and regulatory support we can help simplify raw material qualification and validation efforts. Sartorius CellGenix operates a state-of-the-art GMP facility for production of recombinant proteins and cell processing in Freiburg, Germany. A subsidiary is located near Boston in Portsmouth, NH/USA.
Safe │ GMP Compliant │Reliable
AllCells is the industry leader in the procurement and customization of human-derived hematological tissues and services. With over 23 years of proven expertise, AllCells’ purpose-built infrastructure and quality framework affords the responsiveness, GMP and RUO product diversity, scalability, quality and regulatory standards that our customers in life sciences require as they transition their research from the bench to the clinic.
The MARS® Platform offers label-free, Ficoll gradient-free acoustic cell separation and a matrix-free immunomagnetic cell separation technology to isolate cells using a proprietary multiphysics approach. MARS is completely automated for complete sample preparation and isolation, and provides efficient removal of lysed cell debris, dead cells, and other small particles.
MARS can isolate any number of cell types from blood, bone marrow or dissociated tissue. We have protocols and reagents to isolate neutrophils, monocytes, T cells, tumor cells and tumor infiltrating lymphocytes on MARS.
ASEPTIC TECHNOLOGIES develops, manufactures and markets innovative aseptic solution for the BioPharmaceutical industry.
Its equipment and devices are designed to de-risk aseptic fill and finish, the best-known being the AT-Closed Vial® technology.
The AT-Closed Vial® is based on the unbreakable ready-to-use vial, supplied with stopper in place and remaining closed throughout the filling process, minimizing the contamination risks.
Various equipment offer an easy scale-up from manual to fully automated operation.
The benefits of the technology are: better sterility assurance, fast operations, scalability, increased safety during whole supply chain, strong operating cost reduction.
The AT-Closed Vial® technology is widely used in the Cell and Gene Therapies as it offers uncompromised container closure integrity even during storage at -80°C and cryogenic temperatures.Member of SKAN GroupVisit Website
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 2,200 physicians, investigators and other health care professionals from more than 45 countries. Our mission is dedicated to improving the application and success of bone and marrow transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
ATMP Sweden is a not for profit organisation for communication of Swedish ATMP activities. The communication activities are funded through the Karolinska University hospital.
Looking for an immunotherapy potency assay that can save time, cut costs, and simplify your workflow? Accelerate your pipeline with Axion BioSystems’ Maestro bioelectronic assays. Using advanced electronics to noninvasively measure real-time biological responses, Maestro Z and Maestro ZHT streamline your process. Straightforward and easy to use, track immune cell-mediated killing in 96- and 384-well plates. Assay on timescales from minutes to months with no external labels or dyes. Gain unprecedented access to kinetic responses with exquisite sensitivity. Efficiently move potency assays from development to QC with GMP compliance available.
From Discovery to Delivery™, Azzur Group provides the life science community full life-cycle solutions for all their GxP needs. From Azzur Cleanrooms on Demand™ facilities to our labs, training centers, and consulting offices across the nation, Azzur Group helps organizations start, scale, and sustain their growing enterprises. With nearly four decades of service to the life science community, we have become a trusted partner to the world's leading pharmaceutical, biotechnology, medical device, and healthcare companies, as well as their supply chain.
Barkey is worldwide known for its expertise in medical technology in the field of warming devices and dedicated itself to the scientific research of cell & gene therapy. Our goal is the development of new therapies and subsequently support the upscaling process as well as being part of the manufacturing process. Following our own high-quality principles, we strive for a reliable tech transfer and applying the rules of cGMP. That includes the full transfer through all steps of developing a therapy. From Research & Development to the point of Manufacturing and finally patient administration.
We partner with cell and gene therapy companies to save lives through autologous and allogeneic cellular therapy. We are the only cell and gene therapy solutions provider with customizable services to support the entire end-to-end cell therapy supply chain. As part of the National Marrow Donor Program®/Be The Match®, our organization has sourced, collected and delivered cells from more than 100,000 volunteer allogeneic donors around the world for time-critical cellular therapies. We have extensive experience providing cellular source material consented for research, clinical and commercial use.
Throughout the past 30+ years, we’ve developed and continually enhanced our cell collection network and proven cell therapy supply chain infrastructure. Our teams are responsible for more than 6,500 time-sensitive cell therapy shipments per year. Through the CIBMTR®, we provide long-term follow-up tracking for the first two FDA-approved CAR-T therapies.
Biocair is a global GDP logistics specialist with over 35 years of experience in the pharmaceutical, biotechnology and life sciences sectors.
The company has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled logistics services available whilst delivering flexible, tailored, cost effective solutions to all clients. The Biocair network operates 24/7 in over 160 countries across Europe, Africa, Asia and the Americas.
BioCanRx is Canada’s Immunotherapy Network. Our vision is to cure patients and enhance the quality of life of those living with cancer. We invest in leading edge immune oncology research translating world-class technologies from the lab into early phase clinical trials. BioCanRx provides researchers with access to funding, expertise, training and manufacturing facilities and is a leader in the translation, manufacture and adoption of cancer immunotherapies. biocanrx.com
BioCentriq was founded in 2018 and is a full service CDMO for cell and gene therapy process development and clinical manufacturing. Our ISO-7 certified GMP clinical manufacturing facility is in Newark, NJ. At this facility, we manufacture autologous and allogeneic cell therapies, gene therapies and provide analytical and quality services across several cell types. We offer viral vector production, cell and viral banking and upstream and downstream processing. Additionally, we have the capabilities to manufacture immunotherapies, including monoclonal antibodies and proteins, and vaccines. Our facilities provide full customer access to work in hybrid teams from tech transfer through GMP clinical production. BioCentriq has a BSL-2 certified process development facility located in South Brunswick, NJ to accelerate scale-up and translation activities.
We are vendor and technology agnostic and work with our clients to leverage the optimal technology platform for your product through the development process. In support of our full suite of process development and clinical manufacturing services, the team at BioCentriq offers pre-defined and custom workforce development programs as well as full access to our centers during projects in a unique collaborative approach with our expert scientists to knowledge transfer. Learn more at www.biocentriq.com.
BioLamina AB is a Swedish biotechnology company built on a scientific foundation with a legacy in matrix biology and cell culture-based research. Our flagship products, our biorelevant human recombinant laminin isoforms, Biolaminin®, are defined cell culture matrices that successfully imitate the natural, cellspecific cell-matrix interaction in the cell culture dish, allowing the cells to thrive and maintain their function. Our products are a powerful resource for scientists working with stem cells and primary cells both within basic research as well as in regenerative medicine companies with a focus on cell therapy applications.
A global leader in in-vitro diagnostics for over 55 years, bioMérieux has always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide. The Company is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. It provides diagnostic solutions that improve patient health and ensure consumer safety.
At bioMérieux, we are proud to have a long history in the field of industrial microbiology. Cutting-edge cell and gene therapy products demand state-of-the-art quality control. Your business requires rapid, accurate results you can trust to ensure product safety and protect consumer health. With a comprehensive portfolio of rapid microbiology testing solutions, bioMérieux can help streamline your laboratory workflows, boost efficiency, prevent compliance issues—and ultimately, improve your bottom line.Visit Website
Bionique® Testing Laboratories, Inc. has advanced into an international leading provider of mycoplasma testing services for the life science industry.
Bionique offers a number of testing methods, including a validated GMP compliant Real-Time PCR assay to support all your testing needs. We specialize in mycoplasma testing of cell therapies, cell banks, raw materials, unprocessed bulk harvest and final drug products. Additionally, our highly experienced team has expertise in methods development and validation to support the emerging applications of Rapid Microbial Methods (RMM).Visit Website
BioSharing Network is a partnership between six US blood centers. The network has over a million donors and has decades of experience recruiting and collecting blood products. Our network provides GMP leukopacks, as well as providing support services including flowcytometry, cryopreservation and prodigy-based manufacturing. With multiple donor rooms, clean rooms for manufacturing and strong logistics teams, we are a the most reliable provider in the market.Visit Website
Bio-Techne unites some of Life Sciences’ most distinguished brands including R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple and ACD to deliver a broad array of GMP-compliant high-quality reagents, technologies & services tailored to cell and gene therapy development and production. Our mission is to deliver innovative solutions that enable cell and gene therapies to reach more patients.
Our extensive portfolio includes:
GMP-grade ancillary reagents - Cytokines, media, and antibodies, with customizable packaging available to fit your process
Analytical Solutions - Multiple platforms that enable rapid and accurate analysis of cells, molecules, and contaminants
Process Development and CDMO services – TcBuster™, our non-viral gene delivery system that speeds cell engineering times and increases cargo capacity
Bluechiip understands that every sample is critical, our objective is to manage each one with optimal quality in the most efficient way. Bluechiip’s advanced sample management solution is the only system providing sample temperature with ID in cryogenic environments. Bluechiip delivers confidence in every sample.Visit Website
Carisma Therapeutics’ innovative approach has the potential to create life-changing cellular therapies for patients with cancer and other serious disorders.Visit Website
Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) vectors and CAR-T immunotherapies, with deep experience in viral vector scale-up and production. Catalent recently acquired MaSTherCell, adding expertise in autologous and allogeneic cell therapy development and manufacturing. Catalent has produced 100+ cGMP batches across 70+ clinical and commercial programs.Visit Website
Cellular Highways, a TTP company, is developing a new generation of automated high-throughput, scalable cell sorting instruments for research, diagnostic and therapeutic applications.
Powered by VACS, a new microfluidic cell sorter technology, our instruments will reduce the cost and complexity of cell sorting and achieve far higher throughput than existing platforms, thus making cell sorting accessible to every laboratory as well as enabling new clinical applications.
Our first product, Highway1 is designed for sterile, GMP compatible therapeutic cell sorting. Highway1 is now a beta prototype, and we are looking for testers with challenging needs. Please get in touch if you would like to be a beta tester!Visit Website
Celonic is a privately owned Contract Development Manufacturing Organization (CDMO) with three state-of-the-art sites in the heart of Europe. Celonic is a full-service provider offering development and cGMP manufacturing services for biologics and cell and gene therapies. Our portfolio includes the development of mRNA, viral vector systems, cell lines, and EVs. We also offer analytics for characterization, non-GMP and GMP manufacturing, and fill and finish manufacturing services.
Center for Breakthrough Medicines (CBM) is an innovative cell and gene therapy focused contract development and manufacturing organization located in the heart of “Cellicon Valley” in Greater Philadelphia. CBM’s integrated and comprehensive service offering provides a one-source solution to accelerate speed to market for advanced therapies. A client driven approach coupled with a patient-centric culture delivers high quality and reliable process and analytical development, viral vector manufacturing, GMP testing, cell processing, plasmid production, and cell banking services to support the full product life cycle. Through our relationship with Discovery Labs, CBM is able to access extensive expansion capacity. Currently CBM occupies 700,000 ft2 with an additional 1,000,000 ft2 plus
that can be rapidly retrofitted for clinical and commercial manufacturing allowing clients flexibility in their CMC approach as their pipeline grows and products progress to commercialization.
CCRM, a Canadian public-private partnership funded by the Government of Canada, the Province of Ontario, and leading academic and industry partners, supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. A network of academic researchers, leading companies, strategic investors and entrepreneurs, CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients, with specialized teams, funding and infrastructure. CCRM sources and evaluates intellectual property from around the globe, offers various consulting services, conducts development projects with partners, and establishes new companies built around strategic bundles of intellectual property. CCRM has a fully resourced research facility used to both evaluate and advance technologies, a centre for process development and advanced manufacturing, and a GMP facility within a 40,000 square foot space. CCRM is the commercialization partner of the University of Toronto’s Medicine by Design. CCRM is hosted by the University of Toronto and was launched in Toronto’s Discovery District on June 14, 2011. Visit us at www.ccrm.ca
At Charles River, our focus is always on anticipating tomorrow’s drug development needs today. This is why we have invested in the tools, talent and capacity to further the new frontier of cell and gene therapy development. We can support your cell and gene therapy programs every step of the way, from early discovery, manufacturing of viral vectors, plasmid and autologous/allogenic cells, toxicity/toxicology studies, to analytical release testing of your cell line characterization, biosafety and potency testing.
Our global footprint, team of experienced professionals, and unsurpassed portfolio of integrated services are dedicated to supporting you to help get your product to patients faster. To learn how we can help accelerate your cell and gene therapy goals, visit criver.com/CGT.Visit Website
Cryoport Systems is the life sciences industry’s most trusted provider of temperature-controlled supply chain solutions, serving biopharmaceutical, IVF and surrogacy and animal health organizations around the world. Cryoport Systems’ proprietary Cryoport Express® dry vapor shippers, innovative C3™ 2-8°C & CRT solutions, Cryoportal® logistics management platform, leading-edge Smartpak™ condition monitoring system and geo-sensing technology paired with unparalleled temperature-controlled logistics expertise and 24/7/365 customer support, make Cryoport Systems the end-to-end supply chain partner that you can trust. Cryoport Systems is proud to currently support over 500 regenerative medicine clinical trials and 8 commercial cell and gene therapies.
ECL2 is the U.S. provider of Q-Pulse, a Quality Management System software that has been implemented in over 80 countries worldwide. ECL2 currently supports numerous labs and has been featured in the newest edition of a book written by a widely respected expert on cellular therapy.
Paired with our expertise within the life sciences area and specific to cellular therapy and blood banking, we are in the best position to advise our clientele in best practices relating to the automation of their programs. All of our QMS consultants have been Quality professionals themselves and have been responsible for their own quality systems.
We make the process a seamless one, because we’ve been through it. ECL2 provides a complete solution starting from the initial sale, to delivering training and configuration while also supporting you in your ongoing needs. Our consultants also provide consulting services to those that require additional guidance in developing their Quality Management Systems.
Q-Pulse comes with all of the modules integrated for a comprehensive solution. Allowing you to stay on top of training requirements with visual aids such as matrix views, equipment maintenance based upon a fixed period or on usage, it provides a complete document control solution linked to training plans, manages workflows for corrective and preventative actions, complaints and anything else requiring a workflow. Q-Pulse provides a workload dashboard, so you know what is required of you, your team or entire organization. Q-Pulse also includes audit management, reporting and trending. Please stop by and see us!
Ecolab offers end-to-end contamination control solutions for any stage of cell and gene therapy product development. Our comprehensive approach includes regulatory insights, biocides and disinfectants, Bioquell bio-decontamination systems and services, and isolators.
FUJIFILM Wako Chemicals Europe GmbH is a wholly owned subsidiary of FUJIFILM Wako Pure Chemical Corporation, a world-renowned supplier of high purity chemicals and reagents based in Japan.
With decades of experience developing and manufacturing high quality products as a comprehensive laboratory reagent manufacturer, FUJIFILM Wako Pure Chemical Corporation focuses on the needs of forefront fields of academic research, industry and medical care.
In addition to general laboratory chemicals, we provide reagents for immunological and pathological research, genetic engineering and biochemistry, and recently, we have launched new and unique tools for neuroscience and exosome research.Visit Website
Genesis BPS is a global manufacturer and supplier of precision equipment to clinical laboratories, life science customers, blood collection and cellular therapy organizations. Our product portfolio represents quality and consistency in a world of everchanging requirements for collection, processing, safe storage and transport.
ZipThaw is a dry thawing device setting a new standard for thawing applications. ZipThaw provides consistent, efficient and gentle thawing and warming of fluids requiring high viability. This lightweight, portable unit has a compact footprint, low capital cost and minimizes cross contamination with the use of patented disposables. ZipThaw reduces operating costs and requires virtually no maintenance. ZipThaw has two independent chambers that that provide a hygienic and fast solution to meet your thawing requirements. Visit the Genesis booth to learn more about all of our tools for science including Thawing, Welding and Sealing devices. Genesis BPS...Technology is in our blood!Visit Website
Genezen is a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP vector production, and analytical testing services, building on the company's expansive knowledge and experience in the industry and working with the nation's leading institutions.
Grifols provides high-quality human biological materials for life sciences research and the development and manufacturing of pharmaceutical products.Visit Website
Mill Creek Life Sciences, LLC (MCLS) operates in Rochester, Minnesota and seeks to develop new cellular technologies and regenerative medicine therapies. Our leading products are PLTMax® and PLTGold® human platelet lysate (hPL) used as a media supplement in ex vivo cell culture during the manufacture
of cell, gene, and tissue-engineered products. Through our collaboration with research institutions such as the Mayo Clinic, we develop novel and high-fidelity solutions to issues in both clinical practice and research.
Minaris Regenerative Medicine is a leading global contract development and manufacturing organization (CDMO) dedicated to the production of cell and gene therapy products. For more than 20 years, we have been offering clinical and commercial manufacturing services, development solutions, and technologies while providing outstanding quality and reliability.Visit Website
Mission Bio unlocks the ground truth of cancer through response, relapse, and remission with its Tapestri Platform, powered by single-cell multi-omics. As the first and only to analyze genotype and phenotype simultaneously in single cells, the Tapestri Platform can help unravel the inherent complexity of cancer. Discover how Tapestri enables accurate characterization of your cell and gene therapy candidates for safer and more effective therapeutic strategies. We partner with pharma and biopharma companies across advanced therapy development programs to implement proven single-cell multiomics capabilities into discovery, translational, and clinical research efforts.Visit Website
EDITLife®, user-friendly, fully-automated data and clinical workflow management software for BMT/Cell Therapy clinics and stem cell labs, includes an integrated lab module (LABHero®).Visit Website
MVE Biological Solutions is the leading global manufacturer of vacuum insulated products and cryogenic systems. Over 50 years, we set the standard for storage of biological materials at low temperatures. MVE is the preferred brand for cryogenic equipment in a variety of application areas including bio-pharma cell and gene therapies, storage of cord blood and stem cells, medical research facilities, government institutions, IVF centers, hospitals and clinics, and animal husbandry and livestock.
Myriade develops the VIDEODROP, an innovative nanoscale imaging technology.
Based on the principles of interferometry, the Videodrop makes it possible to measure the size and concentration of biological nanoparticles like lentivirus, adenovirus or retrovirus
Videodrop measures the physical titer of viral vector solutions, so it allows to:
Providing linear results compared to p24 ELISA, VIDEODROP is suitable for "at-line" characterization of lentiviral vectors and in-process controls.Visit Website
Nordmark is a pharmaceutical company that develops and produces ingredients and drug products through all stages of the value chain. As the world's largest manufacturer of pharmaceutical collagenase, we are able to provide translational enzymes - research and GMP Grade collagenase and neutral protease products – to simplify the path from research to the clinic. Our Nordmark Biochemicals division offers products for nearly every cell isolation application, including our highly purified, animal-free Collagenase AF-1 GMP Grade and our excellent Collagenase NB 6 GMP Grade for stem cell isolation. Supporting documentation and access to Drug Master Files are available.Visit Website
Automated CD3/4/8/34/45 counterVisit Website
OriGen Biomedical supplies a complete line of single use disposable products for use in Regenerative Medicine
applications including T-Cell therapies. Our products are FDAcleared, MDSAP-certified, CE-marked, cGMP-manufactured, and ISO 13485:2016 certified.
The PermaLife Cell Culture Bag is an optimal way to protect critical cell cultures. PermaLife has a user-inspired design including a needle-free, luer-actuated adapter which is selfsealing to make it easy to sample, feed, and harvest sensitive cells. The PermaLife is also gas permeable and water impermeable which eliminates the need for a humidified incubator.
The CryoStore™ Freezing Bag is the industry-preferred cryogenic freezing bag. The CryoStore™ Bag is available in a variety of configurations including a number of tubing and multibag options, allowing you to select the product that best fits your process.
The CryoStore™ Multi-Chamber Freezing Bag allows for cryopreservation of small volume blood components for future regenerative medicine applications. Multiple chambers are filled simultaneously through the channel at the bottom of the bag. The individual 4-6mL chambers allows for multiple post thaw applications.
CryoPur™ DMSO Solutions are certified to USP and Ph. Eur. Standards. CryoPur, CryoPur-D, CryoPur-S, and CryoPur-T Solutions come sterile, aseptic filtered and are non-pyrogenic. CryoPur™ Solutions are available as 100% DMSO and a DMSO Dextran mixture. OriGen supplies CryoPur™ in vials and syringes to meet your organization’s needs.
OriGen is known for its customer-driven product development process where OriGen can adapt its products to better fit laboratories’ protocols, not force labs to change protocols to match OriGen’s products. Visit https://www.origen.com/customer-driven-product-developmentprocess for more information.Visit Website
Ossium Health is developing stem cell-based therapies to improve treatment for patients suffering from hematologic diseases, organ transplant rejection, and diseases of inflammation.Visit Website
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.9 billion enterprise. Penn Medicine employs more than 44,000 people in six acute-care hospitals and state-of-the-art outpatient locations, including cutting-edge research facilities, in the city of Philadelphia and throughout the region.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $496 million awarded in the 2020 fiscal year.
In October 2021, Penn Medicine opened the Pavilion, a new hospital building which expands the footprint of the Hospital of the University of Pennsylvania (HUP), becoming a new landmark for exemplary care for the community. The Pavilion is one of the largest hospitals in the U.S.—and the largest in the Philadelphia region. The building rises 17 stories on Penn Medicine’s West Philadelphia campus as a place where Penn’s world-renowned researchers, clinicians, and faculty will continue to pioneer advanced patient care. The $1.6 billion facility houses 504 private patient rooms and 47 operating rooms.Visit Website
PeproTech is a business unit within the Thermo Fisher Scientific Biosciences Division, specializing in manufacturing high quality cytokine products and providing exceptional service to the global life science and cell therapy markets. Our products include Recombinant Human, Murine and Rat Cytokines, Animal-Free Recombinant Cytokines, GMP Cytokines, Antibodies and ELISA Kits.
Proteintech, founded in 2002, is a leading manufacturer of antibodies, proteins and immunoassays. Proteintech has the largest proprietary portfolio of self-manufactured antibodies covering 2/3 of the human proteome. With over 100,000 citations and confirmed specificity, Proteintech offers antibodies and immunoassays across research areas. In addition, Proteintech produces cytokines, growth factors and other proteins that are human expressed, bioactive and cGMP-grade. Proteintech sites are ISO13485 and ISO9001-2015 accredited. ChromoTek is part of Proteintech and is a pioneer in the development and commercialization of innovative reagents based on camelid Nanobodies. Nanobodies consist of only one single polypeptide chain; they are the smallest known antibodies and can be used for many analytical assays.
To learn more about Proteintech and the ChromoTek product line, please visit www.ptglab.comVisit Website
RegMedNet is the website that unites the diverse regenerative medicine and advanced therapies community. Through partnership with our sister journal, Regenerative Medicine, we seek to educate and inspire to help this exciting field move forward at an even faster rate. On RegMedNet, you can find free educational webinars, expert opinion and industry insights, as well as the latest news and advances direct to your inbox. You can watch, listen and read about every step in the regenerative medicine and advanced therapy pipeline, from development, clinical trial and manufacture to regulation and commercialization, all in one place. Sign up today to join our engaged community of scientists, manufacturers, policy makers and more, all for free.
RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and exosome/extracellular vesicle (EV) product and process development to fuel the rapid commercialization of scalable regenerative cures. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and exosome production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type 2 Drug Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under 1 year.
Saint-Gobain Life Sciences is an industry leading provider of material science based solutions for single-use fluid management including TPE and silicone tubing, connection and flow control components, bioprocess and cell culture bags, filtration products and over-molded technology, all available in customized assemblies that are produced in 18 manufacturing facilities located around the world.
We deliver and implement rapid and cost-effective Biomanufacturing solutions from early phase development through scale-up to commercial manufacturing. Benefit from the most comprehensive bioprocess technology portfolio coupled with our expertise in Single-use bioprocess engineering. Our global bioprocess teams are available to discuss your process development and manufacturing requirements.
Scinus Cell Expansion Netherlands BV (Bilthoven, The Netherlands) is a biotech company, developing innovative technologies for cell production. Our mission is to make cell therapies accessible for a global patient population. The core activity is the development and marketing of an innovative bioreactor platform technology for the cell culture industry. The SCINUS bioreactor offers a cost-effective, controlled alternative to conventional cell production strategies. The patented technology allows cell culture professionals to perform the entire cell expansion process, from biopsy to clinically relevant numbers of cells, within one closed system. Therefore, our bioreactor technology is ideal for scale-out of (stem) cell culture. Scinus Cell Expansion also offers services to assist its clients in the translation to a commercial-scale GMP production strategy for their cell products.
About the Stem Cell Network: The Stem Cell Network (SCN) is a national not-for-profit organization that supports three main objectives: stem cell and regenerative medicine research; training the next generation of highly qualified personnel; and supporting the knowledge mobilization and transfer of stem cell and regenerative medicine research. From the lab to the clinic, our goal is to power science that will benefit Canadians. SCN was created in 2001. With support from the Government of Canada, the Network has grown from a few dozen labs to more than 196 world-class research groups, supporting 200+ research projects and 24 clinical trials. Since its inception, 21 biotech companies have been catalyzed and more than 4,000
highly qualified personnel have been trained. In 2021, the Government of Canada demonstrated its continuing trust and support in SCN with an investment of $45 million for the 2022–25 period. For more information visit stemcellnetwork.ca.
VitaCyte manufactures and sells defined collagenase & neutral protease enzymes for cell isolation or recovery of cells after culture. VitaCyte sells three categories of collagenase products: low-cost, defined enriched collagenase products (DE Collagenases) formulated to match traditional collagenase products and GMP-Grade, purified natural or recombinant collagenase. All collagenase products are consistently manufactured (i.e., minimal lot to lot variability) and are > 95% pure. The recombinant collagenase is animal-origin-free.
Stimulating Growth. Cultivating Solutions. – Expert Partner in Stem Cell Bioprocessing Large cell numbers are needed for the development of cell therapies, stem cell-based drug research and future applications such as lab grown meat. By utilizing its strong synergies in cell culture expertise, bioreactor technology, and polymer manufacturing, Eppendorf has emerged as an expert partner for the cultivation of stem cells at large scale.
With our equipment, training programs, and application services, we support scientists in resolving cultivation bottlenecks during the development of advanced stem cell-based applications. The need for advanced solutions is constantly increasing. With our expertise, we help to stimulate the growth of your cultures and cultivate solutions tailored to your challenges.
iVexSol, Inc. is a viral vector manufacturing company founded on a proprietary, next-generation, stable lentiviral vector production process that transforms the way these essential gene-delivery vehicles are made. Our Intelligent ManufacturingTM platform ensures the robust and reliable production of high quality, high-titer vector by generating a clonally derived Master Cell Bank of stable vector-producing cells for the production of your gene of interest. Expansion, harvest and release of a vial from your bank enables us to deliver ready-to-use vector “on demand (i.e., within weeks, not months of your order), preserving and accelerating your clinical development timeline.
Nanotein offers cutting edge ex vivo T Cell activation & expansion for rapid manufacture of clinically potent, long-lasting, stemlike CAR-T cells.
NanoView Biosciences, a Boston-based, privately-held company, is focused on enabling worldwide life science researchers to better understand the biological role of extracellular vesicles, including exosomes and viral vectors, and their potential use as biomarkers for improving the diagnosis, prognosis, treatment, and monitoring of disease. The Company's proprietary products, include the ExoView® R100 and R200.
Developing innovative policies in Korean regenerative medicine and advancing into a hub for Asia and the global Market.
Akadeum Life Sciences is a cell and molecular isolation company that has developed a novel buoyancy-based separation technology for either depletion of unwanted material or positive selection of cells or molecules of interest. Our commercially available kits include a selection of human and mouse cell isolation kits and an RBC depletion kit. Unlike magnetic-based separation methods, microbubbles enable rapid and simple column- and magnet-free isolations. To learn more please visit our booth and explore www.akadeum.com.
AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.
AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.
For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.
CellFE has developed a scalable, high throughput microfluidic device for the efficient delivery of gene-editing molecules into cells. CellFE’s technology uses rapid cell compressions to facilitate cells to act like a sponge by exchanging fluid with their environment and uptaking large molecules.
Curate Biosciences (formerly GPB Scientific, Inc.) enables cell processing that radically changes the outcomes and economics landscape of cell therapy manufacturing. The Curate® Cell Processing System applies Deterministic Cell Separation™ (DCS) technology through a benchtop system and single-use cartridges optimized for T cell isolation. With virtually no cell loss and designed with both manufacturing and clinical potential at the forefront, the Curate® System enables production of CAR-T and other therapeutic cell therapies beyond today's limitations. With strong venture financing from Amgen Ventures, Vensana Capital, and other major healthcare investors, Curate Biosciences is advancing the application of its DCS technology to target additional cell types, disease states, and workflows.
The Curate System is a functionally closed wash, separation, and concentration device designed primarily for integration within the cell therapy workflow and can process standard leukopaks within approximately 40 minutes. The system’s core DCS technology is uniquely gentle on cells, circumvents the need for cell labeling or Ficoll processing for WBC isolation, and enables substantially better recovery (2-fold vs Ficoll-based commercial methods) and purity (99% Platelet and 92% RBC removal).
ExoCoBio is a global leader in exosomes-based biomedicine and regenerative aesthetics.
- The world’s first clinical-grade exosome-specialized GMP (EGMP) facility
- CDMO business: Exosomes & Cells
- Located in Osong, which is South Korea’s first biotech and pharmaceutical cluster
- Two types of advanced exosome production lines dedicated to naive stem cell exosomes of regenerative therapeutics and genetically engineered exosomes for a potential therapeutic portfolio
- The EGMP facility is intended to serve as a crucial platform to resolve the issue of mass production in the exosome field worldwide
- Inflammatory skin disease (atopic dermatitis and others)
- Inflammatory Bowel Disease & Acute Kidney Injury
- IND application in 2024 (E)
- ASCE+™: The world’s first exosomes regenerative aesthetics for skin/hair
- EXOMAGE™/EXOCODE™: Exosome-containing mesotherapy lines for professionals
- CELLTWEET™: Exosome-containing cosmetics for consumers
Innovator across industries that delivers cutting edge solutions for the next generation of pharmacy, biocontainment, and biopharma cleanroom technologies.
At Lonza Cell & Gene, we help customers develop and manufacture innovative medicines through our commitment to science, technology and delivery. Our offering spans across development and manufacturing services, products, tools, and cutting-edge automation systems including the Cocoon® Platform, to develop, de-risk and industrialize therapies from basic research to commercialization. Our scientists and engineers have decades of development experience across a broad spectrum of cell types and technologies, providing you with reliable process and analytical development, GMP manufacturing and regulatory services, which are tailored to meet your needs.
Despite the explosive innovation in therapeutic discovery and development, biomanufacturing innovation and platforms have not kept pace. We intend to change that.
Resilience is a technology-based manufacturing company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains from disruption. Founded in 2020, the Company is building a network of high-tech biomanufacturing platforms and capacity to ensure the medicines of today and tomorrow can be made at the quality, cost, and scale to meet patient needs. Resilience offers solutions for cell and gene therapy services from early clinical through commercial manufacturing including: process and analytical development, cell banking, viral vector production (AAV, LVV), and other viral vectors, immunotherapies, HSCs, iPSCs, and regenerative medicines. We are continuously advancing the science and technology of CGT biomanufacturing by investing heavily in R&D, manufacturing platforms and infrastructure. We focus on deep-rooted partnerships and novel business models. Resilience aims to free its partners’ time and resources to focus on therapeutic discoveries that improve patients’ lives and democratize access to medicines.
For more information, visit www.Resilience.com.
Xcell Therapeutics was founded on September 2015 with a vision to establish leadership in the industry and the advanced therapeutics market. Our company’s mission is to contribute to the future of mankind through advanced science and technology. Our main business is development and manufacturing highly efficient customized media. With CellCor™ as our backbone technology, we would like to shift the trend of using FBS media to chemically defined media. Our lab and HQ are located in Seoul, and our manufacturing facility is located in Yongin, South Korea. We currently have 13 distributors globally, and are active in Europe and US.
THE NEW GENERATION FOR LIVE CELL SHIPMENTS
A fully conditioned portable CO2 incubator for the transport of biological material under laboratory conditions.
Cellbox Solutions is a young technology company developing and marketing innovative logistics solutions for the BioMedTech, Pharmaceutical and Academic sectors.
Our flagship product, the Cellbox portable CO2 incubator, offers the unique opportunity to incubate and cultivate cells during transport - saving time & effort - while maintaining high cell viability and improving the outcome of downstream applications and assays.
Already equipped with a range of state-of-the-art sensors, that regulate and subsequently logs the internal temperature and CO2 during the shipment, Cellbox Solutions will launch the following in 2022:
- Cellbox devices with newly optimised software & tracking features
- Security First - Updated software compliant with CFR21 Part 11
- Complete packaging solutions that will protect your valuable biological material.
Whether the intended transport is by air, sea, road or rail, the Cellbox is the perfect solution for secure and reliable shipping
With Us, What You Ship is What You Get!
Contact us today!
JPT Peptide Technologies is a global provider of quality, state of the art peptide tools for cell based therapies and assays for immunology and cellular immunotherapy. These include our antigen-spanning overlapping peptide pools, PepMix™ Peptide Pools, for T cell assays and epitope discovery, our clinical grade peptide (CGP) for immunotherapy approaches including Adoptive Cell Transfer, peptide therapeutics, pulsing of dendritic cells and cellular immune monitoring as well as our PepStar™ Peptide Microarrays for seromarker discovery and humoral immune monitoring. These tools are available as off-the-shelf products, as well as fully customizable solutions for your specific needs. With decades of experience in synthetic peptide synthesis, and a proven track-record of providing market-leading, superior quality peptide tools for clinical applications, we can partner with you to advance your therapies. Please visit our booth, or contact us directly during the conference to discuss your needs! You can write US-BD@jpt.com.
Minerva Biolabs GmbH is a leading biotechnology company for the development and marketing of detection & elimination kits for the control of microbial contamination. Our core competence lies in the control of mycoplasma, bacteria and viruses in cell cultures and biopharmaceuticals. In addition we employ specialized kits for detection of germs in drinking water and foods as well as the detection of undeclared meat and the quality assurance of halal and vegan products.
Products for the qualification of PCR cyclers or elimination of DNA contamination in the PCR laboratory complete our product portfolio.
Minerva Biolabs also works as a contract manufacturer (CMO) with a special focus on freeze-dried PCR kits for small and large IVD manufacturers.
Peli BioThermal offers the widest range of temperature-controlled packaging and service solutions to the global life sciences industry, including a complete portfolio of services and software to support end-to-end temperature-controlled packaging asset management. From discovery to distribution, our products ensure that delicate life science materials arrive intact and effective. Customers trust us with their most valuable health-giving and life-saving products because of our expertise in ensuring temperature stability is maintained throughout the distribution chain and for our ability to meet them wherever they operate globally. The economic value we bring our customers is total cost of ownership for all our packaging (owned or rented), services and technology offerings.
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platform vertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic development programs. By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering products and services, Synthego is at the forefront of innovation in engineered biology.Visit Website
© 2021 ISCT. All rights reserved.
Site by eConverse Media